Zusammenfassung
Bei der Rheumatoiden Arthritis handelt es sich um eine chronische Gelenkentzündung mit destruierendem Charakter. Sie kann bereits im Jugendalter beginnen, aber auch im Senium sind Neuerkrankungen möglich. Es handelt sich um eine Autoimmunerkrankung, die nicht nur Gelenke, sondern auch innere Organe betreffen kann. Eine frühe Diagnose und eine rechtzeitige Therapie können die Prognose deutlich verbessern.
Literatur
Westhoff G, Schneider M, Raspe H et al. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population—results from the German Rheumatoid Arthritis Population Survey (GRAPS). Rheumatology. 2009;48:650–7; https://doi.org/10.1093/rheumatology/kep045
Guthrie KA, Dugowson CE, Voigt LF et al. Does pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis Rheum. 2010;62:1842–8; https://doi.org/10.1002/art.27459
Kallberg H, Ding B, Padyukov L et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70:508–11; https://doi/10.1136/ard.2009.120899
Svendsen AJ, Junker P, Houen G et al. Incidence of Chronic Persistent Rheumatoid Arthritis and the Impact of Smoking: A Historical Twin Cohort Study. Arthritis Care Res. 2017;69:616–24; https://doi/10.1002/acr.22987
Sundstrom B, Johansson I, Rantapaa-Dahlqvist S. Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study. Rheumatology. 2015;54: 487–93; https://doi/10.1093/rheumatology/keu330
de Hair MJ, Landewe RB, van de Sande MG et al. Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis. 2013;72:1654–8; https://doi/10.1136/annrheumdis-2012-202254
Stolt P, Yahya A, Bengtsson C et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis. 2010;69:1072–6; https://doi/10.1136/ard.2009.114694
Di Giuseppe D, Wallin A, Bottai M et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women. Ann Rheum Dis. 2014;73:1949–53; https://doi/10.1136/annrheumdis-2013-203338
Jin Z, Xiang C, Cai Q et al. Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-analysis of prospective studies. Ann Rheum Dis. 2014;73:1962–7; https://doi/10.1136/annrheumdis-2013-203323
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. New Engl J Med. 2011;365:2205–19; https://doi.org/10.1056/NEJMra1004965
England BR, Thiele GM, Mikuls TR. Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol. 2017;29:57–64; https://doi.org/10.1097/BOR.0000000000000356
Mikuls TR, Payne JB, Yu F et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol 2014;66:1090–100; https://doi.org/10.1002/art.38348
Maradit-Kremers H, Nicola PJ, Crowson CS et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52:722–32; https://doi.org/10.1002/art.20878
Ranganath VK, Elashoff DA, Khanna D et al. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. J Rheumatol. 2005;32:1040–2
Nell VP, Machold KP, Stamm TA et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1731–6; https://doi.org/10.1136/ard.2005.035691
Schellekens GA, Visser H, de Jong BA et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43:155–63; https://doi.org/10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741–9; https://doi.org/10.1002/art.11223
De Rycke L, Peene I, Hoffman IE et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis. 2004;63:1587–93; https://doi.org/10.1136/ard.2003.017574
Kellner H, Schmidt W, Rau R. Imaging procedures in rheumatology. Differential diagnosis using various imaging procedures in rheumatoid arthritis (RA). Z Rheumatol. 2005;64:553–6; https://doi.org/10.1007/s00393-005-0720-x
Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–81; https://doi.org/10.1002/art.27584
Smolen JS, Landewe R, Bijlsma J et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76:960–77; https://doi.org/10.1136/annrheumdis-2016-210715
Combe B, Landewe R, Daien CI et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76: 948–59,; https://doi.org/10.1136/annrheumdis-2016-210602
Kruger K, Wollenhaupt J, Albrecht K et al. [German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]. Z Rheumatol. 2012;71:592-603; https://doi.org/10.1007/s00393-012-1038-0
Braun J, Kay J. The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2017;16:289–302; https://doi.org/10.1080/14740338.2017.1273899
Taylor PC, Keystone EC, van der Heijde D et al. Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis. New Eng J Med. 2017; 376: 652–62; https://doi.org/10.1056/NEJMoa1608345
Singh JA, Hossain A, Mudano AS et al. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017;5: CD012657; https://doi.org/10.1002/14651858.CD012657
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keyßer, G., Schäfer, C. Die Rheumatoide Arthritis. MMW - Fortschritte der Medizin 160, 50–58 (2018). https://doi.org/10.1007/s15006-018-0001-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-018-0001-7